2005
Successful Inspection Brings Company One Step Closer to European Approval; Drug Eluting Stent Milestone Results in Payment to Novartis in Third Quarter Indianapolis, Ind. - Guidant Corporation...
Innovative Technology Directed Toward Compliance in Heart Failure Patients at Risk of Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced...
European Commission Ruling Necessitates Organizational and Staffing Adjustments Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that as a result of the European Commission...
Approval Sufficient for Completion of Pivotal Trial Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company has received approval from the U.S. Food and Drug...
Guidant Announces Full Availability of Cardiac Rhythm Management Product Line Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a third quarter dividend of $0.10 per share on outstanding common stock. This...
Company Expects to Resume Implants and Distribution by Mid-week Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today that it received U.S. Food and Drug Administration (FDA) approval to...
Robert J. Myerburg, M.D., Internationally Recognized Leader in Electrophysiology Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Dr. Robert J. Myerburg, Professor of...
CE Mark Clears Way for Guidant to Reenter Market Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today that it received Conformité Européenne (CE) Mark approval to launch its CONTAK...
Guidant Updates Corrective Actions Regarding Its VENTAK PRIZM AVT, VITALITY AVT, and CONTAK RENEWAL AVT Implantable Cardiac Defibrillators Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said...
Worldwide implantable defibrillator revenue of $470 million, up 3 percent Worldwide coronary stent revenue of $118 million, down 2 percent Worldwide revenue from emerging businesses of $97...
District Court for Delaware Upholds Validity of Mirowski Patent Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it won a key decision in a heart failure device patent...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today it is voluntarily advising physicians about important safety information regarding certain devices. Guidant apprised FDA of this...
Data From Study Will Support Launch of XIENCE V Coronary Stent System Outside the United States Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE: GDT) today announced that the company...
Study Designed to Evaluate the Safety and Efficacy of Surgical Microwave Ablation Technology to Treat Common Heart Arrhythmia Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation...
Guidant Reiterates its Previous Physician and Patient Recommendations Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today that FDA has classified its June 17, 2005 and June 24, 2005...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today it is voluntarily advising physicians about important safety information regarding certain devices. Guidant apprised FDA of this...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced its intention to establish an independent panel of experts to recommend guidelines for when to disseminate information to...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today it is voluntarily advising physicians about important safety information regarding certain devices. Guidant has apprised FDA of...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) initiated a communication to physicians regarding the clinical performance of its VENTAK PRIZM® 2 DR Model 1861 implantable defibrillator....
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it has received Investigational Device Exemption (IDE) conditional approval from the U.S. Food and Drug Administration...
Guidant Shareholders Overwhelmingly Approve Acquisition Agreement with Johnson & Johnson
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) announced that at a special meeting of shareholders held today in Indianapolis, Guidant shareholders overwhelmingly approved the agreement...
New Brunswick, N.J., and Indianapolis, Ind. - Johnson & Johnson and Guidant Corporation today announced that they have been notified, as anticipated, that the European Commission has decided to...
Company Completes Several Merger-Related Milestones During Quarter Sales of products other than worldwide coronary stents were $838 million, up 10 percent Worldwide implantable defibrillator...